ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 644211 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 644211; 2) Community: the network communities that were significantly associated with the response to NSC 644211; 3) Molecule: the relationships between components within communities and NSC 644211; 4) MDR: the compounds that were significantly associated with the NSC 644211.

NSC Compound Enrichment Correlation
NSC 630703 Acridomide 0.0282295482823984 0.23156607
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0282295482823984 0.29561205
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0282295482823987 0.28118512
NSC 671031 Null 0.0282295482823987 0.33143266
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0282295482823987 0.42711627
NSC 646005 Null 0.0282295482823988 0.33776863
NSC 646379 Null 0.0282295482823988 0.0079187147
NSC 646859 Null 0.0282295482823988 0.1375507
NSC 648263 Null 0.0282295482823988 0.47700645
NSC 654376 ANTINEOPLASTIC-654376 0.0282295482823988 -0.0058523257
Total:114  Current:72    [First] [Prev] [Next] [Last]